Sourced from:Direct from Manufacturer
Quick Summary
Ribaxa+ 150mg Tablet
Last updated on 20 Apr 2026 | 04:51 AM (IST)
₹9579
MRP: ₹13122
(You Save ₹3543)
60 TABLET(s) IN A BOTTLE
Sourced from:Direct from Manufacturer
27% OFF
₹9579
MRP: ₹13,122.00
Inclusive of all taxes
27% Off
Product Discontinued
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Olanamo 150mg Tablet
SHIVNAAM TRADEL...
₹ 95.97/tablet
39% cheaper
Zeparib 150mg Tablet
ZEE LABORATORIE...
₹ 98.47/tablet
38% cheaper
Olzapar 150mg Tablet
DELARC PHARMACE...
₹ 132.55/tablet
16% cheaper
Ibyra 150mg Tablet
ZYDUS CADILA
₹ 136.18/tablet
14% cheaper
Introduction
Ribaxa 150mg Tablet contains Olaparib, a PARP inhibitor (Poly ADP-ribose polymerase inhibitor). It plays an important role in managing certain types of cancer, like prostate cancer and metastatic pancreatic cancer. Ribaxa 150mg Tablet helps by targeting and blocking the PARP enzyme that cancer cells use to repair their DNA, making them more likely to die.
Your doctor may prescribe Ribaxa 150mg Tablet alone or along with other anti-cancer medicines, depending on your health condition. Before starting, inform your doctor if you have any pre-existing issues like liver, lung, heart, or kidney diseases.
The ribaxa 150mg price may vary based on the pharmacy, location, and availability, so it is recommended to check with a reliable source before purchasing.
It’s not recommended during pregnancy and breastfeeding as it may cause harm to the baby. For women of reproductive age, a pregnancy test is usually advised before beginning treatment. For men, sperm donation should be avoided for at least three months after completing therapy.
Uses
Ribaxa 150mg uses are:
Treatment of prostate cancer
Treatment of metastatic pancreatic cancer
Used as maintenance therapy after chemotherapy in some cancers
If you’re wondering about Ribaxa 150mg uses, your oncologist will guide you based on your specific cancer type and stage.
How Ribaxa 150mg Tablet works
Ribaxa 150mg Tablet works by inhibiting the PARP enzyme, a key DNA repair enzyme in cancer cells. By blocking this repair mechanism, Ribaxa 150mg Tablet increases cancer cell death, especially in tumours with impaired DNA repair.
This targeted action slows cancer progression and improves survival outcomes in eligible patients.
Interaction of Ribaxa 150mg Tablet with Other Drugs
Before starting Ribaxa 150mg Tablet, inform your doctor about:
All prescription and non-prescription drugs
Any vitamin supplements or herbal products
Certain medicines may alter the Ribaxa 150mg Composition, increasing the risk of side effects or reducing its effectiveness.
Storage conditions
Store Ribaxa 150mg Tablet at room temperature between 20°C to 25°C
Keep it in the original packaging
Protect from moisture, heat, and direct sunlight
Keep out of reach of children
If you miss a dose, skip it if it’s close to your next scheduled dose. Do not double up.
How to take Ribaxa 150mg Tablet
Dosage and duration will be decided by your oncologist
Swallow the tablet whole with water
Do not crush, chew, or break the tablet
Take it with or without food, preferably at the same time each day
Your doctor may adjust your dose depending on your response and tolerance.
Safety advice
Pregnancy
Ribaxa 150mg Tablet may harm your unborn baby. Inform your doctor if you are pregnant, planning pregnancy, or think you could be pregnant.
Breast Feeding
Avoid breastfeeding during and for at least one month after completing Ribaxa 150mg Tablet therapy, as it may pass into breast milk.
Lungs
Tell your doctor if you have any lung-related diseases, as Ribaxa 150mg Tablet may affect lung function.
Liver
If you have liver problems, inform your doctor before starting Ribaxa 150mg Tablet. Dose adjustments may be needed.
Alcohol
The interaction between Ribaxa 150mg Tablet and alcohol is not clearly established. It’s best to ask your doctor.
Driving
Ribaxa 150mg Tablet can cause dizziness, fatigue, or weakness. Avoid driving or using heavy machinery if you feel unwell.
Side Effects
Like all medicines, Ribaxa 150mg Tablet may cause side effects, but not everyone gets them. Ribaxa 150 mg side effects are
Common Side Effects:
Shortness of breath
Nausea
Vomiting
Fatigue
Indigestion
Loss of appetite
Dizziness
Diarrhea
Headache
Serious Side Effects:
Neutropenia (low neutrophil count)
Acute myeloid leukaemia (rare)
Leukopenia (low white blood cells)
Thrombocytopenia (low platelets)
Lung-related issues like inflammation or scarring
If you experience any severe or unusual symptoms, contact your doctor immediately.
Expert Tips
Take Ribaxa 150mg Tablet at the same time daily for better treatment consistency.
Stay hydrated and eat a balanced diet to help manage side effects.
Avoid sun exposure; use sunscreen with SPF 50 or more.
Refrain from consuming grapefruit or grapefruit juice, as it may raise Ribaxa 150mg Tablet levels in your blood.
Regular blood tests are essential to monitor your blood counts and organ function during treatment.
FAQs
Q1.
What is Ribaxa 150mg Tablet used for?
Ribaxa 150mg uses include treating prostate cancer and metastatic pancreatic cancer, often after chemotherapy.
Q2.
Can Ribaxa 150mg Tablet be taken during pregnancy or breastfeeding?
No, it’s not recommended during pregnancy or breastfeeding due to potential harm to the baby.
Q3.
Are there any dietary restrictions while using the Ribaxa 150mg Tablet?
Avoid grapefruit products, as they can affect the levels of Ribaxa 150mg Tablet in your blood.
Q4.
Can Ribaxa 150mg Tablet cause low blood cell counts?
Yes, Ribaxa 150mg Tablet may lower your red blood cell, white blood cell, and platelet counts. Regular monitoring is advised.
Q5.
Are there any alternatives to the Ribaxa 150mg Tablet?
If Ribaxa 150mg Tablet alternatives are needed, your oncologist will suggest the most suitable options based on your condition and treatment goals.
Fact Box
Molecule Name | Olaparib |
Therapeutic class | Antineoplastic agents |
Pharmacological class | Poly Adenosine Diphosphate-Ribose Polymerase (PARP) inhibitor |
Indications | 1. Treatment of Prostate cancer 2. Metastatic Pancreatic cancer |
References
Lynparza, United States Food and Drug Administration (USFDA), [Revised on May 2020], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
AstraZeneca UK Limited, European Medicines Compendium (emc), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.9204.pdf
AstraZeneca Pharmaceuticals LP, [Revised on November 2023], [Accessed on March 2024], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/00997c3f-5912-486f-a7db-930b4639cd51/00997c3f-5912-486f-a7db-930b4639cd51_viewable_rendition__v.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vikas B S
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 20 Apr 2026 | 04:51 AM (IST)
Want to know more?
Read Our Editorial Policy
